Beitherapy-Canheal
BEITHERAPY-CANHEAL · Topics

Menstrual pain and endocannabinoids: is there a role for cannabis?

Menstrual cramps, prostaglandins and endocannabinoid signaling: what is known, why cannabis evidence is limited, and when symptoms need assessment.

When period pain needs attention

Dysmenorrhea means painful menstruation. Primary dysmenorrhea occurs without an identified underlying pelvic disease; secondary dysmenorrhea may result from endometriosis, adenomyosis or another gynecological condition. Severe pain that interrupts work, study or daily life deserves assessment rather than being dismissed as normal.

Why menstrual cramps hurt

Prostaglandins released around menstruation stimulate uterine muscle contractions and contribute to pain. This is why medicines such as ibuprofen or naproxen, when appropriate for the patient, are established first-line options: they reduce prostaglandin production.

The endocannabinoid research question

ECS components have been described in the endometrium, uterine muscle and pain-processing pathways, and their activity can change with the cycle. This supplies a plausible reason to study cannabinoid signaling in menstrual pain, but is not proof that cannabis treats primary dysmenorrhea.

What evidence is missing

Some people report using cannabis for gynecological pain, but targeted, high-quality randomized trials for primary dysmenorrhea remain limited. Studies need standardized products, comparator treatments and meaningful measures of pain, functioning and side effects.

CBD and THC are not interchangeable

CBD does not produce the same intoxication as THC but can still have adverse effects or interact with medications. THC may affect coordination, attention and mood, and its risks rise in some people or circumstances. A mechanism involving CB1 or CB2 does not identify an appropriate product or dose.

Do not overlook the underlying cause

Pain worsening over time, heavy bleeding, pain between periods or pain with intercourse may merit evaluation for secondary causes such as endometriosis. Symptomatic relief should never delay that assessment. Cannabinoid use should also be reviewed with a clinician when pregnancy is planned.

Key conclusion

Research on the ECS and menstrual pain is scientifically plausible, but reliable clinical evidence for cannabis as a routine treatment for primary period cramps is not established. Diagnosis, proven treatment options and individualized safety remain central.

Source article and references

This article is an editorial adaptation of the Hebrew original.

Read the Hebrew source article ↗

Ask about individual guidance

Speak with our team to find out whether guidance is appropriate for your situation.

WhatsApp ↗